Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Faergeman

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Ugeskrift for Laeger|January 5, 2002
[Vascular surgeon is on the look-out for a like-minded internist]O Faergeman
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1990
Total mortality in cardiovascular risk factor intervention trialsO Faergeman
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1990
Action limits in hyperlipidemiaO Faergeman
Ugeskrift for Laeger|May 14, 1990
[Physicians and cholesterol]O Faergeman
Acta Medica Scandinavica|January 1, 1973
Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycinO Faergeman
Journal of Internal Medicine|April 25, 2006
Introduction: Apolipoproteins and guidelines for prevention of cardiovascular diseaseO Faergeman
European Heart Journal|January 29, 2002
Estimation and reduction of cardiovascular risk in old peopleO Faergeman
Acta Physiologica Scandinavica|October 2, 2002
Methods for detecting coronary disease: epidemiology and clinical managementO Faergeman
Ugeskrift for Laeger|June 26, 2001
[Om trans fatty acids from cow's stomach]O Faergeman
Danish Medical Bulletin|December 1, 1987
What is the importance of changes in plasma lipids caused by antihypertensive drugs?O Faergeman
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Ugeskrift for Laeger|January 5, 2002
[Vascular surgeon is on the look-out for a like-minded internist]O Faergeman
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1990
Total mortality in cardiovascular risk factor intervention trialsO Faergeman
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1990
Action limits in hyperlipidemiaO Faergeman
Ugeskrift for Laeger|May 14, 1990
[Physicians and cholesterol]O Faergeman
Acta Medica Scandinavica|January 1, 1973
Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycinO Faergeman
Journal of Internal Medicine|April 25, 2006
Introduction: Apolipoproteins and guidelines for prevention of cardiovascular diseaseO Faergeman
European Heart Journal|January 29, 2002
Estimation and reduction of cardiovascular risk in old peopleO Faergeman
Acta Physiologica Scandinavica|October 2, 2002
Methods for detecting coronary disease: epidemiology and clinical managementO Faergeman
Ugeskrift for Laeger|June 26, 2001
[Om trans fatty acids from cow's stomach]O Faergeman
Danish Medical Bulletin|December 1, 1987
What is the importance of changes in plasma lipids caused by antihypertensive drugs?O Faergeman
Pageof 17